Antibodies and variants thereof against PD-L1

TREATMENT OF PD-L1-NEGATIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY AND AN ANTI-CTLA-4 ANTIBODY

BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28

Anti-PD1 and anti-CTLA4 antibodies

Antibodies to programmed cell death protein 1

Antibodies binding to human CD3 at acidic pH

Bispecific antibody specifically binding to GPNMB and CD3, and use thereof

ANTI-SIRP ALPHA ANTIBODIES

MULTISPECIFIC ANTIGEN BINDING PROTEINS

CD47 antibodies and uses thereof for treating cancer

ANTI-SIRP ALPHA ANTIBODIES

Humanized anti-VEGF antibody Fab fragment and use thereof

Monoclonal antibodies against alpha-synuclein fibrils

Nucleic acids encoding anti-gliadin antibodies

IMMUNOGENETIC RESTRICTION ON ELICITATION OF ANTIBODIES

Single domain antibodies to SARS-CoV-2 nucleocapsid protein

ROR1 ANTIBODY IMMUNOCONJUGATES

Notch receptors with hinge domain

NOVEL ANTI-PD-L1 ANTIBODY AND USES THEREOF

TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1/LAG-3, PREPARATION METHOD THEREFOR, AND USE THEREOF

TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1/TGF-beta, PREPARATION METHOD THEREFOR, AND USE THEREOF

Anti-Vβ17/anti-CD123 bispecific antibodies

Anti-CD47 antibodies and uses thereof

TREM2 ANTIBODIES AND USES THEREOF

CLAUDIN 6 ANTIBODIES AND USES THEREOF

ANTIBODIES TARGETING CDH19 FOR MELANOMA

Interleukin-31 monoclonal antibodies for veterinary use

MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR TNFA AND IL-17A, ANTIBODIES TARGETING IL-17A, AND METHODS OF USE THEREOF

Separating agent

Trispecific and/or trivalent binding proteins

Site-specific glycoengineering of targeting moieties

PLECTIN-1 BINDING ANTIBODIES AND USES THEREOF

Method of treating a tumor using anti-TfR antibodies

Humanized anti-human OX40 monoclonal antibody, preparation method therefor and use thereof

ST2 antigen binding proteins

Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseases

ANTI-PD-L1 ANTIBODIES AND USES THEREOF

Anti-B7-H3 antibody

CD3-SPECIFIC BINDING MOLECULES

Anti-TREM2 antibodies and methods of use thereof

Antibodies to MAdCAM

Anti-CD47 antibody and application thereof

ANTI-CLAUDIN18.2 ANTIBODY AND USE THEREOF

C3-binding agents and methods of use thereof

Medicinal composition containing monoclonal antibody or antibody fab fragment thereof, and use thereof

PATHOGEN BINDING PROTEINS

Monoclonal antibodies specific for the PB2 antigen of the human influenza A virus (flu), nucleotide sequences, method and diagnostic kit for flu infection

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

CELLULAR VAMP CLEAVAGE ASSAY

Fc variants with altered binding to FcRn

Therapeutic molecules

ANTI-OX40 ANTIBODIES AND THEIR USES

Agonistic anti-tumor necrosis factor receptor 2 antibodies

TRISPECIFIC PROTEINS AND METHODS OF USE

ANTIGEN-BINDING MOLECULE COMPRISING ALTERED ANTIBODY VARIABLE REGION

Antigen-binding proteins that activate the leptin receptor

CD1a antibodies and uses thereof

Monoclonal antibodies against the beta chain region of human TRBV9

NOVEL BISPECIFIC ANTIBODY MOLECULE AND BISPECIFIC ANTIBODY SIMULTANEOUSLY BINDING TO PD-L1 AND LAG-3

BIFUNCTIONAL MOLECULES WITH IL-7 ACTIVITY

BI-SPECIFIC ANTIBODIES FOR ENHANCED TUMOR SELECTIVITY AND INHIBITION AND USES THEREOF

ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION, AND COMPOSITIONS, COMBINATIONS AND METHODS FOR USE THEREOF

FORMULATIONS OF ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

Anti-ANGPTL 3/8 complex antibodies and methods of using the same

NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF

Anti-matrix metalloproteinase 7 (MMP-7) inhibitory antibody and uses thereof

ANTI-EpCAM ANTIBODIES, COMPOSITIONS COMPRISING ANTI-EpCAM ANTIBODIES AND METHODS OF MAKING AND USING ANTI-EpCAM ANTIBODIES

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

ANTI-GITR ANTIGEN-BINDING DOMAINS AND USES THEREOF

Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies and Uses Thereof

Method of treating asthma with anti-IL1RAP antibodies

MULTI-TARGETING FUSION PROTEIN FOR BLOCKING THE GROWTH OF VASCULAR ENDOTHELIAL CELLS AND ACTIVATING T CELLS AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

SPR-BASED BINDING ASSAY FOR THE FUNCTIONAL ANALYSIS OF MULTIVALENT MOLECULES

METHOD FOR GENERATING AVID-BINDING MULTISPECIFIC ANTIBODIES

CD73 ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-CD40 ANTIBODIES FOR USE IN TREATMENT OF HIDRADENITIS

GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) ANTIBODIES AND METHODS OF USE THEREOF

ANTI-ALK2 ANTIBODIES AND USES THEREOF

ACTRIIB BINDING AGENTS AND USES THEREOF

MODIFIED FC FRAGMENT, ANTIBODY COMPRISING SAME, AND APPLICATION THEREOF

ANTI-PD-1 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND PHARMACEUTICAL USE THEREOF

IL-18 BINDING MOLECULES

HEAVY CHAIN ONLY ANTIBODIES TO PDGF

10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use

HIV-1 neutralizing antibodies and uses thereof

Pooled NK cells from umbilical cord blood associated with antibodies and their uses for the treatment of disease

USE OF MCM5 AS A MARKER FOR GYNAECOLOGICAL CANCERS

METHOD OF PRODUCING A BINDER-TOXIN FUSION PROTEIN IN A PLANT CELL OR A WHOLE PLANT

METHODS FOR INDUCIBLE EXPRESSION

Transferrin receptor-binding molecules, conjugates thereof and their uses

Antibodies for Botulinum Neurotoxins

NOVEL HUMANIZED ANTIBODIES AGAINST FACTOR XI HAVING ANTI-THROMBOTIC AND ANTI-INFLAMMATORY EFFECT AND USES THEREOF

HER2/neu-specific antibodies and methods of using same

Anti-glyco-MUC1 antibodies and their uses

MULTI-SPECIFIC PROTEIN MOLECULES AND USES THEREOF

Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof

Site-specific antibody-drug conjugation through glycoengineering

Monoclonal antibody that specifically binds to CD20

Antibodies that bind to IL1RAP and uses thereof

Methods of treating disorders associated with excess or unwanted killer cell lectin-like receptor subfamily g member 1 (KLRG1) expressing t cells with KLRG1 depleting antibodies

Galectin-7-specific monovalent antibodies and uses thereof

ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES

Antibodies Directed Against Programmed Death-1 (PD-1)

IMMUNE TARGETING MOLECULES AND USES THEREOF

ANTI-B7S1 POLYPEPTIDES AND THEIR USE

Activatable Anti-CTLA-4 Antibodies and Uses Thereof

ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF

Methods and compositions for modulating beta chain mediated immunity

Antigen binding proteins

FCMR-binding molecules and uses thereof

HETERODIMERIC FUSION PROTEIN

Antibodies against TIM3 and uses thereof

CONSTRUCTS TARGETING LABYRINTHIN OR A PORTION THEREOF AND USES THEREOF

METHODS OF NEUTRALIZING IL-8 BIOLOGICAL ACTIVITY

Manufacturing Methods To Control C-Terminal Lysine, Galactose And Sialic Acid Content In Recombinant Proteins

Protein binding to fibronectin B domain

Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders

AGGRECAN BINDING IMMUNOGLOBULINS

Antibodies recognizing tau

Antibodies against clostridium difficile toxins and methods of using the same

EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF

Nano-antibody and its application based on SARS-CoV-2 S protein S1 subunit

FUSION PROTEIN AND HIGH-DENSITY LIPOPROTEIN MEASUREMENT KIT USING SAME

Extracorporeal devices for methods for treating diseases associated with anti-neutrophil cytoplasmic antibodies

Anti-PD-L1 diabodies and the use thereof

GLYCOENGINEERED ANTIBODY DRUG CONJUGATES

Anti-TMPRSS2 antibodies and antigen-binding fragments

Anti-BCMA antibody-drug conjugates and methods of use

Methods of use of anti-TNFα antibodies

Monoclonal antibody against CD19 antibody and application thereof

BISPECIFIC ANTIBODIES WITH TETRAVALENCY FOR A COSTIMULATORY TNF RECEPTOR

CD133-BINDING AGENTS AND USES THEREOF

Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES

Monoclonal antibodies against human interleukin-4 receptor alpha, encoding nucleic acids thereof and method of use thereof to treat IL-4 or IL-4/IL-13-mediated diseases

Binding proteins and methods of use thereof

HUMANIZED ANTI-AXL ANTIBODIES

BTN3A binding proteins and uses thereof

Humanized anti-human PD-L1 monoclonal antibody and preparation method therefor and use thereof

Antibodies binding to vista at acidic pH

ACTIVATABLE MASKED ANTI-CTLA4 BINDING PROTEINS

Antibodies specific to delta 1 chain of T cell receptor

BIVALENT BISPECIFIC ANTIBODY AND PREPARTION METHOD THEREOF, CODING GENE, HOST CELL AND COMPOSITION

SEMA4D antibody, preparation method therefor and use thereof

HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF

IL-6 binding molecules

Antibody that binds to VEGF-A and ANG2 and methods of use

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains

PD-1 POLYPEPTIDE VARIANTS

Novel Methionine Containing Antibodies for Conjugation of Agents

A LIQUID FORMULATION OF HUMANIZED ANTIBODY FOR TREATING IL-6-MEDIATED DISEASES

INTRABODIES TARGETING POST-TRANSLATIONAL MODIFICATIONS OF NATIVE PROTEINS AND METHOD FOR OBTAINING THEM

Binding molecules for BCMA and CD3

Anti-idiotypic antibodies against anti-KLK2 antibodies

Humanised Anti Kallikrein-2 Antibody

FIXAXFX BISPECIFIC ANTIBODY WITH COMMON LIGHT CHAIN

Human monoclonal antibody human CD134 (OX40) and methods of making and using same

Multispecific antibodies against CD40 and CD137

Treatment of cancer using humanized anti-BCMA chimeric antigen receptor

CD137 agonist antibodies and uses thereof

METHODS AND COMPOSITIONS RELATING TO GLP1R VARIANTS

The use of anti-CCR7 mabs for the prevention or treatment of graft-versus-host disease (GvHD)

Anti-human CSF-1R antibody and uses thereof

Anti-CTLA-4 Binding Proteins and Methods of Use Thereof

ANTI-CTLA4 ANTIBODIES AND METHODS OF USE THEREOF

MULTISPECIFIC ANTIGEN BINDING PROTEINS CAPABLE OF BINDING CD19 AND CD3, AND USE THEREOF

Antibodies to TIGIT

METHODS OF USING BUTYROPHILIN ANTIBODIES FOR TREATING HIV INFECTION

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

Antibody binding to human IL-1β, preparation method therefor and use thereof

Polypeptides comprising immunoglobulin single variable domains targeting TNFA and IL-23

ANTIBODIES AGAINST LIF AND DOSAGE FORMS THEREOF

LTBP complex-specific inhibitors of TGFβ and uses thereof

Isoform-selective TGFB1 inhibitors and use thereof

Anti-TauC3 antibodies and uses thereof

ANTIBODY CONSTANT REGION VARIANT

IGG FC Variants for Veterinary Use

PREPARATION COMPRISING ANTI-PCSK9 ANTIBODY AND USE THEREOF

Glycan-Interacting Compounds and Methods of Use

Anti-tissue factor antibodies, antibody-drug conjugates, and related methods

Anti-factor IX padua antibodies

NOVEL POLYPEPTIDES

ANTI-CD39 ANTIBODIES

Oncostatin M receptor antigen binding proteins

Anti-FLTantigen binding proteins

Anti HLA-G specific antibodies

Anti-PD-L1 Binding Proteins and Methods of Use Thereof

Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereof

Monoclonal antibodies that bind specifically to human TRBV9

BAFF-R BISPECIFIC T-CELL ENGAGER ANTIBODY

CD3-binding molecules capable of binding to human and non-human CD3

Anti-PAR-2 antibodies and methods of use thereof

MONOCLONAL ANTIBODIES AGAINST ENDOTROPHIN AND THE USE THEREOF

Human IL-23 antigen binding proteins

ANTIBODIES TO MISFOLDED TDP-43 AND METHODS OF USE

Monoclonal antibodies, compositions and methods for detecting complement factor D

Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions

Anti-IL-23 antibodies, compositions, methods and uses

Humanized influenza monoclonal antibodies and methods of use thereof

TETRAVALENT MULTISPECIFIC ANTIBODIES

Antibody for Specifically Binding to Lysyl-tRNA Synthetase N-Terminal Domain Exposed to Extracellular Membrane

ANTI-CARBONIC ANHYDRASE IX ANTIBODY

Anti-Abeta Antibodies

ANTIBODY MOLECULES THAT BIND PD-L1 AND CD137

Anti-IL4 Receptor Antibodies for Veterinary Use

ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF

Antibodies

Antibody molecules that bind CD137 and OX40

Humanized and affinity matured antibodies to FcRH5 and methods of use

Antibodies against ILT2 and use thereof

IMMUNOGLOBULIN A ANTIBODIES AND METHODS OF PRODUCTION AND USE

Anti-IL-6 antibody

Anti-Alpha-Synuclein Antibodies and Uses Thereof

MODIFIED PRODUCT OF FC DOMAIN OF ANTIBODY

Relaxin immunoglobulin fusion proteins and methods of use

COMBINATION OF HER2/NEU ANTIBODY WITH HEME FOR TREATING CANCER

Highly sensitive particle enhanced assay for the quantification of NT-proBNP

Heterodimeric antibodies that bind CD3 and tumor antigens

BISPECIFIC ANTIBODY FOR MEMBRANE CLEARANCE OF TARGET RECEPTORS

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

Anti-HER2/anti-4-1BB bispecific antibodies and uses thereof

ANTIBODIES SPECIFIC TO MUC18

Anti-CD38 antibodies and methods of use

CD73 BLOCKING ANTIBODIES

Humanised anti-IL17BR antibody

Anti-ALK2 antibody

Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer

PD1 AND/OR LAG3 BINDERS

Combination Therapy for the Treatment of Cancer

Tandem diabody for CD16A-directed NK-cell engagement

Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof

LAIR-1-binding agents and methods of use thereof

Antibody that binds to VEGF and IL-1beta and methods of use

ANTI-FGF19 ANTIBODIES

ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR USE IN INTERVENTION AND THERAPY OF CONGESTION IN A PATIENT IN NEED THEREOF

Anti-Abeta antibodies

Anti-Abeta antibodies

Anti-abeta antibodies

Monoclonal Antibodies Against Pathological Alpha-Synuclein, and Methods Using Same

POLYPEPTIDE TARGETING APTAMERS FOR CHARACTERIZATION, CAPTURE, AND CLINICAL MANAGEMENT OF CIRCULATING TUMOR CELLS

METHODS OF TREATING OCULAR CANCER USING ANTI-MET ANTIBODIES AND BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET

Library of antigen-binding molecules including modified antibody variable region

Materials and methods for multidirectional biotransportation in virotherapeutics

Compositions and methods for treatment of diabetic macular edema

MODIFIED ANTIBODY FCS AND METHODS OF USE

HER2 S310F SPECIFIC ANTIGEN-BINDING MOLECULES

Multispecific antibodies against CD40 and CD137

Anti-human CD45RC antibodies and uses thereof

Anti-ILT4 antibodies and antigen-binding fragments

Anti-L1CAM antibodies and uses thereof

Antibody against human cardiac troponin i and use thereof

Antibody against human cardiac troponin I and use thereof

Neutralizing anti-influenza A antibodies and uses thereof

Composition comprising recombinant GPlbα receptor protein

ANTIBODIES MODIFIED FOR TRANSGLUTAMINASE CONJUGATION, CONJUGATES THEREOF, AND METHODS AND USES

DEEP LEARNING-BASED METHOD FOR PREDICTING BINDING AFFINITY BETWEEN HUMAN LEUKOCYTE ANTIGENS AND PEPTIDES

TETRAHEDRAL ANTIBODIES

REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIA ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIGEN BINDING MOLECULES COMPRISING LIPOCALIN MUTEINS

Highly efficient anti-TFPI antibody composition

Muscle targeting complexes and uses thereof for treating dystrophinopathies

ANTIBODY THERAPEUTICS THAT BIND CD137

Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs

Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)

LEUCOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR NEUTRALIZING ANTIBODIES

Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatment

Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof

Immunosuppresive agent

BIFUNCTIONAL MOLECULE DIRECTED AGAINST HUMAN PD-1

CD3 binding antibodies

Humanized and affinity-matured anti-CEACAM1 antibodies

ANTIBODY VARIABLE DOMAINS TARGETING DLL3, AND USE THEREOF

ANTIBODY EPITOPE

Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules

Human antibodies to human delta like ligand 4

Human antibodies to Fel d1 and methods of use thereof

Antibodies and therapeutic uses thereof

Misfolded TDP-43 binding molecules

Anti-ETEC adhesin protein antibodies and methods of use

Neutralizing anti-influenza b antibodies and uses thereof

RECOMBINANT ANTIBODY OF ANTI-HUMAN N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE

Humanized anti-CD79B antibodies and immunoconjugates and methods of use

Bispecific binding molecules binding to VEGF and Ang2

ACTIVATABLE BISPECIFIC ANTIBODIES

Agonistic CD28 antigen binding molecules targeting Her2

MAGEB2 binding constructs

Bispecific antibody binding to TfR

Anti-TNFR2 antibody and use thereof

EGFR binding proteins and methods of use

Therapeutic antibodies and their uses

Anti-B7-H3 antibody, preparation method therefor, conjugate and application thereof

EFFICIENTLY EXPRESSED EGFR AND PD-L1 BISPECIFIC BINDING PROTEINS

TIGIT and CD112R blockade

Antibodies Blocking DLL4-Mediated Notch Signalling

ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES

Method for isolation of soluble polypeptides

Dual cytokine fusion proteins comprising IL-10

ANTI-CDH6 ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE